| First Author | Allan CM | Year | 2019 |
| Journal | J Lipid Res | Volume | 60 |
| Issue | 4 | Pages | 869-879 |
| PubMed ID | 30598475 | Mgi Jnum | J:274332 |
| Mgi Id | MGI:6287624 | Doi | 10.1194/jlr.M091322 |
| Citation | Allan CM, et al. (2019) An upstream enhancer regulates Gpihbp1 expression in a tissue-specific manner. J Lipid Res 60(4):869-879 |
| abstractText | Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1), the protein that shuttles LPL to the capillary lumen, is essential for plasma triglyceride metabolism. When GPIHBP1 is absent, LPL remains stranded within the interstitial spaces and plasma triglyceride hydrolysis is impaired, resulting in severe hypertriglyceridemia. While the functions of GPIHBP1 in intravascular lipolysis are reasonably well understood, no one has yet identified DNA sequences regulating GPIHBP1 expression. In the current studies, we identified an enhancer element located approximately 3.6 kb upstream from exon 1 of mouse Gpihbp1. To examine the importance of the enhancer, we used CRISPR/Cas9 genome editing to create mice lacking the enhancer (Gpihbp1 (Enh/Enh)). Removing the enhancer reduced Gpihbp1 expression by >90% in the liver and by approximately 50% in heart and brown adipose tissue. The reduced expression of GPIHBP1 was insufficient to prevent LPL from reaching the capillary lumen, and it did not lead to hypertriglyceridemia-even when mice were fed a high-fat diet. Compound heterozygotes (Gpihbp1 (Enh/-) mice) displayed further reductions in Gpihbp1 expression and exhibited partial mislocalization of LPL (increased amounts of LPL within the interstitial spaces of the heart), but the plasma triglyceride levels were not perturbed. The enhancer element that we identified represents the first insight into DNA sequences controlling Gpihbp1 expression. |
